InsidersTradesSigma
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
16
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Larry Abensur, Chairman & CEO. Officer active across 1 company, notably BIOSYNEX. Aggregated, 32 reports have been published. Breakdown: 16 buys · 12 sells. Total volume traded: €3.4m. Activity tracked since 19 April 2021. The latest transaction was disclosed on 25 February 2025 (Acquisition). Regulator: AMF. The full history is free.
Companies and markets linked to Larry Abensur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
25,000 shares@ €1.280.6% of flowActionEuronext Growth ParisISIN FR00110059332025DD1022653
Canonical exit: 26 May 2025 (T+90)
11,169 shares@ €1.31420.3% of flowActionEuronext Growth ParisISIN FR00110059332025DD1022654
Canonical exit: 28 May 2025 (T+90)
42,987 shares@ €1.13080.9% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020600
Canonical exit: 20 May 2025 (T+90)
42,987 shares@ €1.13080.9% of flowActionEuronext Growth ParisISIN FR00110059332025DD1021002
Canonical exit: 13 May 2025 (T+90)
1,599 shares@ €1.000.0% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020913
43,187 shares@ €1.19291.0% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020898
Canonical exit: 15 May 2025 (T+90)
49,017 shares@ €1.201.1% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020899
Canonical exit: 18 May 2025 (T+90)
55,590 shares@ €1.001.1% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020908
30,741 shares@ €1.30350.8% of flowActionEuronext Growth ParisISIN FR00110059332025DD1020743
Canonical exit: 14 May 2025 (T+90)
627,651 shares@ €0.010.1% of flowDPSHors plateforme de négociationISIN FR001400WOK32025DD1018146
1,800 shares@ €17.310.6% of flowActionEuronext Growth ParisISIN FR00110059332022DD822670
Canonical exit: 22 May 2022 (T+90)
5,200 shares@ €17.811.8% of flowActionEuronext Growth ParisISIN FR00110059332022DD822686
Canonical exit: 22 May 2022 (T+90)
5,000 shares@ €16.901.6% of flowActionEuronext Growth ParisISIN FR00110059332022DD822262
Canonical exit: 18 May 2022 (T+90)
2,746 shares@ €17.600.9% of flowActionEuronext Growth ParisISIN FR00110059332022DD822248
Canonical exit: 17 May 2022 (T+90)
2,000 shares@ €17.6380.7% of flowActionEuronext Growth ParisISIN FR00110059332022DD822233
Canonical exit: 16 May 2022 (T+90)
254 shares@ €17.59260.1% of flowActionEuronext Growth ParisISIN FR00110059332022DD822244
Canonical exit: 16 May 2022 (T+90)
2,500 shares@ €17.49130.8% of flowActionEuronext Growth ParisISIN FR00110059332022DD822229
Canonical exit: 16 May 2022 (T+90)
2,000 shares@ €25.401.0% of flowActionEuronext Growth ParisISIN FR00110059332021DD757888
Canonical exit: 10 Aug 2021 (T+90)
2,100 shares@ €24.501.0% of flowActionEuronext Growth ParisISIN FR00110059332021DD757887
Canonical exit: 11 Aug 2021 (T+90)
7,800 shares@ €25.503.8% of flowActionEuronext Growth ParisISIN FR00110059332021DD757883
7,067 shares@ €26.29113.6% of flowActionEuronext Growth ParisISIN FR00110059332021DD746972
40,883 shares@ €26.545621.0% of flowActionEuronext Growth ParisISIN FR00110059332021DD746969
9,931 shares@ €26.10125.0% of flowActionEuronext Growth ParisISIN FR00110059332021DD746968
12,926 shares@ €26.1496.5% of flowActionEuronext Growth ParisISIN FR00110059332021DD746001
9,193 shares@ €26.04714.6% of flowActionEuronext Growth ParisISIN FR00110059332021DD745998
25 of 32 declarations
About Larry Abensur
LARRY ABENSUR is Chief Executive Officer and Chairman of BIOSYNEX. He has been reported in 32 transactions, and across the 32 sampled filings, purchases total EUR 793818 and sales total EUR 2708036, between 2021-12-08 and 2025-02-28.
